SSTR3 agonists significantly modulate excitatory synaptic properties, perturbating neuron excitatory–inhibitory balance (E/I) [59], a parameter frequently altered in many brain disorders, including autism spectrum disorder (ASD) [60]. This evidence concerns the gene SSTR3 and autism spectrum disorder.